Validic, Sutter Health partnership tests data transfer of wearables

Validic and Sutter Health have partnered together to conduct a pilot project to see how patient-generated health data (PGHD) can be shown to improve patient care and outcomes.

The collaboration focuses on the using Sutter’s Mpower app on patient smartphones and Validic’s VitaSnap to transfer data to provide patient data to improve efficiency when transferring information.

Patients with diabetes can especially benefit from remote monitoring wearables that can measure blood sugar and blood pressure. The data can then be sent to the patient’s physician, who can then alert the patient of an emergency and provide immediate care if needed.

The partnership enrolled patients from Sutter Health with Type II diabetes and gave them the Mpower app, which can sync with multiple devices that measure glucose levels, blood pressure and level of activity. The app then calculates the data in visual representations to motivate them to stay on track with their care and alert physicians when an emergency is detected.

 

 

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.